Jennifer Sasson, MD’s clinical trial indicating a treatment for asthma and eczema may improve survival rate for patients hospitalized with moderate to severe COVID-19 has received widespread national news coverage. Jennifer and her team of UVA collaborators including William A. Petri, MD published their study in the scientific journal Open Forum of Infectious Diseases.
Filed Under: Clinical, Media Highlights, Research